Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Treatment Optimization of Cetuximab in Patients With Metastatic Colorectal Cancer Based on Tumor Uptake of 89Zr-labeled Cetuximab Assessed by PET

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2016 by VU University Medical Center
Sponsor:
Information provided by (Responsible Party):
Laura Pijpers, VU University Medical Center
ClinicalTrials.gov Identifier:
NCT01691391
First received: May 15, 2012
Last updated: April 28, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)